AGFA Gevaert NV
XMUN:AGE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
AGFA Gevaert NV (AGE) under the Base Case is 0.161 EUR per share.
Compared with the current market price of 0.327 EUR, the stock appears
Overvalued by 51% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What AGFA Gevaert Does
AGFA Gevaert makes imaging and printing products and software. Its business is split between healthcare and printing. In healthcare, it sells digital radiology systems, image management software, and related services that help hospitals and clinics capture, store, and review medical images. In printing, it sells offset printing plates, chemicals, and workflow systems that help commercial printers prepare and produce printed materials.
- Headquarters
- Belgium BE
- Employees
- 4 211
- IPO date
- May 31, 1999
Balance Sheet
Recent Events
Latest Earnings Call
Agfa says its transformation is on track, while faster cloud migration weighs on near-term HealthCare IT profitability; management sees hydrogen recovery ahead and advances the DPS–EFI combination.
Open the earnings call- EPS
- −€0.10
- Expected
- −€0.05
- Surprise
- −100.0%
- Stock, day of the call
- −6.9%
Past 12 months
Continue AGE Research
Decided on AGFA Gevaert? Get an email when AGE reaches the price you’d buy at. Free with an account.
Other AGFA Gevaert listings
What is the Intrinsic Value of one AGE stock?
The intrinsic value for
AGFA Gevaert NV (AGE) under the Base Case is 0.161 EUR.
Is AGE stock undervalued or overvalued?
Compared with the current market price of 0.327 EUR, the stock appears Overvalued by 51% .